Fresenius Medical Care AG & Co. KGaA operates within the Kidney dialysis centers sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Fresenius Medical Care AG & Co. KGaA with three other
health care providers in Europe:
sales of 3.42 billion Euro [US$3.82 billion]
Ramsay Generale De Sante SA
(2.24 billion Euro [US$2.50 billion]
of which 79%
was Hospitals/Surgery), and
Rhoen Klinikum AG
(1.23 billion Euro [US$1.38 billion]
of which 97%
was Acute Care).
During the year ended December of 2018, sales at
Fresenius Medical Care AG & Co. KGaA were 16.55 billion Euro (US$18.49 billion).
decrease of 7.0%
versus 2017, when the company's sales were 17.78 billion Euro.
Contributing to the drop in overall sales was the 10.2% decline
in North America, from 12.88 billion Euro to 11.57 billion Euro.
There were also decreases in sales in
Latin America (down 4.6% to 686.49 million Euro)
Corporate / Eliminations (down 0.1% to 14.74 million Euro)
However, these declines were partially offset by the increase in sales of
Emea (up 1.6% to 2.59 billion Euro)
Asia-Pacific (up 4.1% to 1.69 billion Euro)